Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...

Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

TAS-205 showed no significant impact on motor function in patients with Duchenne muscular dystrophy (DMD), highlighting the ongoing search for effective treatments for the rare condition.

Multifaceted Mechanisms and Future of Diabetic Wound Healing and the rapidly evolving subject area, we are pleased to ...

The authors investigated the potential role of IgG N-glycosylation in Haemorrhagic Fever with Renal Syndrome (HFRS), which may offer significant insights for understanding molecular mechanisms and for ...

Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...

Clinical trials are well-controlled, regimented studies that test new ways to treat, prevent, screen for, or care for a certain disease. Each trial usually has a narrow purview, such as testing a ...

A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...